Histopathological examination confirmed invasive ductal carcinoma (grade II) with infiltrative growth, ER/PR/AR positivity (90%), and TRPS1 expression, confirming mammary origin. This evidence concerns the gene TRPS1 and invasive ductal breast carcinoma.